Immune checkpoint inhibitors, which have revolutionized the treatment of several cancer types, are now being developed to target new checkpoints. These novel inhibitors aim to block different immune-suppressing proteins found in cancer cells, thereby enhancing the immune system’s ability to destroy these cells.
Read more